Full title: Robotic surgical system for minimally invasive total hysterectomy with or without salpingoophorectomy for beningn disease or prophylactic surgery
Authors: González-Hernández, Y, Trujillo-Martín, MM, Herrera-Ramos E, García-Pérez, L, de la Flor-López, M
Contact person: Yadira González Hernández (yadira.gonzalezhernandez@sescs.es)
KEY POINTS
- Benign uterine diseases are highly prevalent in women, especially during their reproductive years. These pathologies can manifest with symptoms such as pelvic pain, abnormal vaginal bleeding, anemia, fatigue, and reproductive dysfunction, significantly impacting quality of life and potentially requiring, eventually, surgical treatments such as hysterectomy.
- Hysterectomy is the most frequently performed gynecological procedure for treating benign uterine conditions. It is also employed as a prophylactic surgery in high-risk patients due to genetic mutations.
- Initial studies on the HUGO™ RAS robotic surgical system show promising preliminary results in terms of surgical times and complication rates.
- The HUGO™ RAS system has the potential to be a valuable complement to existing minimally invasive surgical technologies
- The current evidence base is very limited, and no ongoing studies have been identified for this specific application. It is essential to conduct robust, prospective studies with a sufficient sample size to definitively confirm the effectiveness and safety of this technology for minimally invasive hysterectomy.
DOCUMENTOS:
